Other groups detected inactivation of both p38 and ERK1/2 pathways as well as activation of caspase 3 and alteration of the Bcl-2/BAX ratio when HCC cells were treated with lidocaine; in addition, viability was reduced and apoptosis increased in exposed cells (93). The gene discussed is BAX; the disease is hepatocellular carcinoma.